grandhope biotech co ltd-a
(300238:Shenzhen)

Last CNY20.64 CNY

Change Today +0.35 / 1.72%

Volume 3.1M

300238 On Other Exchanges

Symbol

Exchange

300238:CH

Shenzhen

As of 3:00 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

grandhope biotech co ltd-a (300238) Snapshot

Open CNY20.22		Previous Close CNY20.29
Day High CNY20.77		Day Low CNY20.19
52 Week High 06/1/12 - CNY39.90		52 Week Low 12/3/12 - CNY13.03
Market Cap 2.5B		Average Volume 10 Days 5.0M
EPS TTM CNY0.30		Shares Outstanding 122.2M
EX-Date 05/16/13		P/E TM 68.8x
Dividend CNY0.10		Dividend Yield 0.48%

Current Stock Chart for GRANDHOPE BIOTECH CO LTD-A (300238)

300238:CH Historical Stock Quote
300238:CH Advanced Stock Chart

Related News

No related news articles were found.

grandhope biotech co ltd-a (300238) Related Businessweek News

No Related Businessweek News Found

grandhope biotech co ltd-a (300238) Details

Grandhope Biotech Co., Ltd, a bio-tech company, develops, manufactures, and markets regenerative medical devices for the treatment of damaged tissue and organs in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue used for the closure of dura mater during neurosurgery; ThormalGEN, a product that is used for surgical repairs; and DermalGEN, a wound dressing product used for burns, scalds, and wounds due to skin loss or trauma. The company is also involved in the research and development of products in the areas of membranes, conduits, bones and ligament, and collagens. Grandhope Biotech sells its products through a sales network in China and internationally. The company was founded in 1999 and is headquartered in Guangzhou, China.

Detailed 300238:CH Company Description...

www.grandhopebio.com

Founded in 1999

grandhope biotech co ltd-a (300238) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

grandhope biotech co ltd-a (300238) Key Developments

Grandhope Biotech Co., Ltd. Announces Final Cash Dividend Implementation Plan for 2012 Payable on May 16, 2013

May 13 13

Grandhope Biotech Co. Ltd. announced final cash dividend implementation plan for 2012 for A shares of CNY 1.00000000 per 10 shares (tax included) payable on May 16, 2013 with record date as on May 15, 2013 and ex-date May 16, 2013.

Grandhope Biotech Co., Ltd to Report Q1, 2013 Results on Apr 18, 2013

Apr 18 13

Grandhope Biotech Co., Ltd announced that they will report Q1, 2013 results on Apr 18, 2013

Grandhope Biotech Co., Ltd Proposes Profit Distribution of 2012; Proposes Amendments to its Articles of Association

Mar 26 13

Grandhope Biotech Co. Ltd. proposed the 2012 profit distribution plan with cash dividend (tax included) of CNY 1.00000000 per 10 shares in the annual general meeting to be held on April 16, 2013. The company proposed amendments to the company's articles of association in the annual general meeting to be held on April 16, 2013.